HyprView is the world's first high throughput multimodal imaging platform, combining advanced photonics and AI to deliver clinical-grade, label-free imaging for precision oncology diagnostics. Our platform enables faster, more cost-effective tissue analysis without the need for chemical staining.
By overlaying HyprView optical modalities on the H&E baseline, pathologists gain richer, multimodal insights from a single tissue sample. Our label-free imaging approach provides instant results, eliminating the delays and costs associated with traditional chemical processing while preserving the sample for downstream analysis.
HyprView supports a broad range of oncology applications, empowering researchers, pathologists, and clinicians with high-resolution, AI-enhanced imaging for improved diagnostic confidence and patient outcomes.
Learn more or get in touch with the HyprView team at www.hyprview.com.